Galapagos is a biotechnology company whose core activity lies in the development and manufacture of innovative medicines, particularly in the fields of oncology and immunology. The company's activities include the development of cell therapies and small molecules, as well as the production of CAR-T cells and biologics. The company has a decentralized cell therapy production platform and a comprehensive pipeline of medicines in various stages of development.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Development of clinical drug substance candidates for autoimmune diseases and inflammatory conditions, including identification, acquisition, development, and clinical programs.
Partnerships and collaborations
Collaborations with biopharmaceutical partners for the joint advancement of programs and the implementation of financing and development structures.
Shareholder and investor information
Provision of financial reports, stock information, shareholder information, corporate governance, as well as webcasts, events and downloadable materials for investors and analysts.
Press releases and corporate communications
Publication of press releases on business developments, regulatory information, share buybacks, results and corporate decisions.
Knowledge
No knowledge articles yet
Once Galapagos GmbH has claimed this profile, we'll publish editorial articles and case studies here together.